Perbedaan Akbar Indo Makmur Stimec Tbk dan Merck Tbk.: Akbar Indo Makmur Stimec Tbk diperdagangkan di Rp390 (kapitalisasi pasar 84,48 M, volume 24 jam 98,4 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.890 (kapitalisasi pasar 1,75 T, volume 24 jam 23,8 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 20,7× kapitalisasi pasar Akbar Indo Makmur Stimec Tbk, dan Akbar Indo Makmur Stimec Tbk lebih aktif diperdagangkan (98,4 rb vs 23,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| AIMS | MERK | |
|---|---|---|
Kapitalisasi Pasar | 84,48 M | 1,75 T |
Volume | 98,4 rb | 23,8 rb |
Lot | 984 | 238 |
Perputaran | 38,54 jt | 92,73 jt |
Harga Rata-rata | 391,68 | 3.896,01 |
Nilai Transaksi | 38,54 jt | 92,73 jt |
Harga Ekuilibrium Indikatif | 384 | 3.930 |
Volume Ekuilibrium Indikatif | 200 | 3 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.
Selengkapnya di halaman AIMS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →